Literature DB >> 27758692

Pharmaceutical Cocrystal: An Antique and Multifaceted Approach.

Prabhakar S Panzade1, Giridhar R Shendarkar1.   

Abstract

BACKGROUND: Pharmaceutical cocrystal is an emerging approach to tailor physicochemical and mechanical properties of drug substances. Cocrystals are composed of API and pharmaceutically acceptable coformer. It is used to address the solubility, dissolution, mechanical properties and stability of drugs.
METHODS: This review discusses introduction to cocrystal, preparation, and characterization, what USFDA says on cocrystal and role of Hansen solubility parameter to predict cocrystal. The effect of cocrystal on drug properties, dependence of cocrystal solubility on pH, concept of drug-drug cocrystal, and aerosil 200 as novel cocrystal former and impact of cocrystal on drug pharmacokinetic has also been presented in this review along with highly selected examples of cocrystals. Finally, how cocrystal offers an opportunity for patents is also delineated.
RESULTS: Pharmaceutical cocrystals have ability to tailor physichochemical and mechanical properties of drug substances. It also provides opportunity for patentable invention. Therapeutic efficacy of drugs may be improved via drug-drug cocrystal.
CONCLUSION: The pharmaceutical cocrystals are not fully explored and have potential for future development. Successful drug delivery can be achieved through cocrystallization. Pharmaceutical industry will be beneficial through successful cocrystallization of drug substances. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Aerosil 200; Hansen solubility parameter; USFDA; cocrystal; coformer; drug drug cocrystal

Mesh:

Substances:

Year:  2017        PMID: 27758692     DOI: 10.2174/1567201813666161018152411

Source DB:  PubMed          Journal:  Curr Drug Deliv        ISSN: 1567-2018            Impact factor:   2.565


  1 in total

1.  Preparation and characteristics of a novel PETN/TKX-50 co-crystal by a solvent/non-solvent method.

Authors:  Lei Xiao; Shuangfeng Guo; Hongping Su; Bingwang Gou; Qiaoe Liu; Gazi Hao; Yubing Hu; Xiaohong Wang; Wei Jiang
Journal:  RSC Adv       Date:  2019-03-21       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.